biobide

FEBRUARY 2, 2024

Children and adolescents lack robust preclinical models to replicate the pathologies and provide precise and targeted therapies. This is why not many Pharma companies specifically specialize in discovering and developing pediatric cancer treatments; a great example of advancing new therapies for childhood cancer is the biotech Oncoheroes.

Disease 59

Disease Medical Schools Pharma Companies Clinical Trials 59

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. It is approved in Argentina as the world’s first therapy for severe Chronic Fatigue Syndrome and is the only late-stage drug in the U.S. Ampligen is AIM’s TLR3 agonist immune-system modulator. development pipeline for ME/CFS.

Clinical Trials 52

Clinical Trials Trials Virus Therapies 52

Drug Patent Watch

JANUARY 9, 2025

Enter the Contract Development and Manufacturing Organization (CDMO) a lifeline for many startups looking to bring their innovative therapies to market. The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation.

Compliance 52

Compliance Drug Development Therapies Pharma Companies 52

The Pharma Data

OCTOBER 20, 2020

In hopes to advance the best and brightest, MD Anderson, in partnership with The Focus Fund GP, has launched the Cancer Focus Fund to propel compelling investigational cancer therapies from preclinical development through Phase II clinical trials. But now they’ll be choosing the therapies themselves. .

Clinical Trials 52

Clinical Trials Therapies Pharma Companies Trials 52

The Pharma Data

SEPTEMBER 11, 2020

In an effort to slow the spread of the disease and prevent a second wave, pharma companies around the world are continuously looking to advance new methods of treatment. This week’s round up dives into developments from companies based in Australia and the US. Saama Technologies, Inc. , Source link.

Clinical Trials 52

Clinical Trials Pharma Companies Trials Hospitals 52

H1 Blog

MAY 10, 2023

Nurses, Treatment Leaders & A New Brand of KOL In addition to their frontline roles in patient care, nurses are increasingly serving as key opinion leaders (KOLs) for pharma companies on new treatments and medicines – leveraging their expertise on the latest developments in healthcare research and clinical trials.

Nurses 52

Nurses Doctors Pharma Companies Clinical Trials 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … The Perceptron was designed to improve the accuracy of computer predictions.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

Vial

MARCH 1, 2024

Growth factors for this market included the growing size of the pharmaceutical industry, the increasing number of clinical trials , substantial funds dedicated to pharma and biotech R&D, and the growing biosimilars and generics market. By geographical region, the global CRO services market in 2023 was dominated by North America.

Clinical Trials 52

Clinical Trials Clinical Research Trials Laboratories 52

Predictive Oncology

FEBRUARY 7, 2023

“We’re providing that richness of tumor diversity and the population diversity that normally the companies will not be able to see until they are in a clinical trial and [the drug is] challenged against a multitude of different patients.”

Clinical Trials 52

Clinical Trials Pharmaceutical Companies Trials Pharmaceuticals 52

Vial

FEBRUARY 19, 2024

From co-founding Acerta Pharma to pioneering patient-centric innovations, Dr. Hamdy shares his impactful career. Explore the groundbreaking VersAptx bioconjugation platform, designed to elevate cancer therapies and uncover the delicate balance between clinical excellence and commercial viability in the dynamic landscape of pharmaceuticals.

Small Molecule 52

Small Molecule Therapies Treatment Science 52

The Anticancer Fund

JUNE 7, 2022

This is another study that is strongly supportive of replication and further development, including clinical trial development. In both newly diagnosed and recurrent PDX models the drug was shown to be non-toxic and to have meaningful anti-GBM activity - including a survival benefit.

Clinical Trials 40

Clinical Trials Drugs Trials Treatment 40

The Pharma Data

NOVEMBER 10, 2020

When a company engages a CRO, they most often turn over full control of their study or preclinical trials to this contractor – in other words, they “outsource” their research. By giving companies full control of their studies, they are able to significantly speed up timelines,” Tessier said.

Marketing 52

Marketing Science Pharma Companies Research 52

The Pharma Data

OCTOBER 14, 2020

Food and Drug Administration granted Breakthrough Therapy designation to France-based Inventiva’s experimental NASH treatment lanifibranor. In this 24-week clinical trial, lanifibranor met the primary endpoint with a statistically significant reduction of the Steatosis Activity Fibrosis score. adults age 65 and older.

Clinical Trials 52

Clinical Trials Trials Pharmaceuticals Therapies 52

H1 Blog

DECEMBER 11, 2024

These forecasts highlight the key changes poised to transform the healthcare and pharma landscapes. In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Additionally, well see a move to multi-indication trials to maximize profitability.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Treatment 52

The Pharma Data

MAY 13, 2021

Unfortunately, I learned the hard way that the “Big Pharma” companies don’t care about their patients. And the best part was this: over the two year trial, the treatment had ZERO side effects making it completely safe. That’s right, if you’re suffering from pain, then “Red Light Therapy” is about to become your new best friend.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

DECEMBER 30, 2020

In September 2020, the trials were halted to investigate a potentially severe side effect in a UK patient, transverse myelitis, an inflammation of part of the spinal cord. After a short break, the trial restarted in the UK and other parts of the world, but was delayed for much longer in the U.S. With a market cap of $1.6

Vaccine 52

Vaccine FDA Trials Therapies 52

ACTO

NOVEMBER 25, 2024

“Our ambition is to become the first pharma company powered by artificial intelligence at scale, giving our people tools and technologies that focus on insights and allow them to make better everyday decisions. … The Perceptron was designed to improve the accuracy of computer predictions.

Clinical Trials 52

Clinical Trials Trials Pharma Companies Pharmaceuticals 52

Drug Target Review

MARCH 13, 2025

Negative data is often much larger in size than published data because it includes raw data from failed experiments, clinical trials with no significant effect and studies with null results. Techbio companies have initiated this approach.

Drug Development 52

Drug Development Science Clinical Trials FDA 52